Form 4: Director Robert Bessler Sells LifeStance Health Shares

Director Robert Bessler reported the sale of 69,899 shares of LifeStance Health Group, Inc. common stock via Rule 10b5-1 trading plans.

Summary

• Director Robert Bessler sold a total of 69,899 shares of LifeStance Health Group, Inc. (LFST) common stock.
• Transactions occurred on April 23, 2026, and April 24, 2026.
• Sales were executed through entities Vitthal LLC and Shama LLC.
• The sales were conducted pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Weighted average sale prices ranged from $7.00 to $7.095 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sales were conducted under a pre-planned 10b5-1 arrangement, which is standard practice for corporate insiders.

Positives

• The transactions were executed under a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for insiders to sell stock without triggering concerns regarding non-public information.

Negatives

• The sale represents a reduction in the director's indirect beneficial ownership of company stock.

Risks

• Continued insider selling can sometimes be perceived negatively by retail investors as a lack of confidence in near-term share price appreciation.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a routine corporate governance activity and does not necessarily reflect a change in the director's outlook on the company's long-term fundamentals.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate insiders to manage liquidity while maintaining compliance with SEC regulations.

Stakeholder Impact

• Shareholders should note the reduction in insider holdings, though the pre-planned nature of the sale mitigates potential negative sentiment.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

LifeStance Health, LFST, Insider Trading, Form 4, Director Sale, Rule 10b5-1